September 15, 2025

GLP-1 May Aid Fertility, Raise Risks

Pregnancies occur within six months of GLP-1 use as contraception at initiation stays low.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 12, 2025

Maternal Health and Vitiligo: First Scoping Review Protocol

Protocol outlines review of vitiligo pregnancy outcomes, methods, and planned data mapping.

Conexiant

September 10, 2025

Medical Societies Challenge Kennedy

"That you can no longer trust the recommendations out of the CDC is just devastating."

Conexiant

September 10, 2025

Prenatal Acetaminophen and ADHD/ASD: Linked?

Review of 46 human studies links prenatal acetaminophen to higher ADHD/ASD risk; evidence is heterogeneous; cohort effect sizes are generally modest but larger in some biomarker studies; authors advise cautious, short‑term use under medical guidance.

Conexiant

September 09, 2025

ACOG Reaffirms COVID-19 Vaccine Guidance

 Although CDC recently removed its explicit pregnancy and lactation call-out for the updated COVID-19 vaccine, ACOG is standing firm.

Conexiant

September 04, 2025

'No Standard of Care' for GLP-1 Weaning

Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates

KFF Health News

September 03, 2025

Policy Shift Adjusts NIH Peer Review Role

New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants.

KFF Health News

September 02, 2025

OTC Contraception Pill Linked to More Birth Control Starts

Over-the-counter access to progestin-only oral contraceptives shows higher use among patients with prior pregnancies and those not receiving recent contraceptive counseling.

Conexiant